Lin’s new chapters

Lin Bioscience looks ahead to Taiwan, U.S. listings to fund clinical programs

Taiwanese biotech Lin Bioscience Inc. and its wholly owned San Diego subsidiary Lin Bioscience Co. Ltd. are planning sequential listings in Taiwan and the U.S. to fund clinical programs targeting different markets.

Lin has two preclinical

Read the full 354 word article

How to gain access

Continue reading with a
two-week free trial.